Input: 
There were 13 missense mutations identified in the xenograft that were not present in the patient's primary tumor and there were no new nonsense mutations.
Output:
The entities in this sentence are:
{"genetic_effect": [missense mutations], "model_type": [xenograft], "tumour_type": [primary]}
There are 3 entities in total. Now I will print out the sentence for 3 times, each time with only one entity marked, the rest of the sentence will be exactly the same as the original sentence.
(1) There were 13 <genetic_effect>missense mutations</genetic_effect> identified in the xenograft that were not present in the patient's primary tumor and there were no new nonsense mutations.
(2) There were 13 missense mutations identified in the <model_type>xenograft</model_type> that were not present in the patient's primary tumor and there were no new nonsense mutations.
(3) There were 13 missense mutations identified in the xenograft that were not present in the patient's <tumour_type>primary</tumour_type> tumor and there were no new nonsense mutations.


Input: 
Here we present the detailed molecular, cellular, genetic and epigenetic characterization of an orthotopic xenograft derived from a high-risk stage 4 neuroblastoma patient.
Output:
The entities in this sentence are:
{"molecular_char": [molecular, cellular, genetic, epigenetic characterization], "model_type": [orthotopic xenograft], "cancer_stage": [stage 4], "diagnosis": [neuroblastoma]}
There are 7 entities in total. Now I will print out the sentence for 7 times, each time with only one entity marked, the rest of the sentence will be exactly the same as the original sentence.
(1) Here we present the detailed <molecular_char>molecular<molecular_char>, cellular, genetic and epigenetic characterization of an orthotopic xenograft derived from a high-risk stage 4 neuroblastoma patient.
(2) Here we present the detailed molecular, <molecular_char>cellular</molecular_char>, genetic and epigenetic characterization of an orthotopic xenograft derived from a high-risk stage 4 neuroblastoma patient.
(3) Here we present the detailed molecular, cellular, <molecular_char>genetic</molecular_char> and epigenetic characterization of an orthotopic xenograft derived from a high-risk stage 4 neuroblastoma patient.
(4) Here we present the detailed molecular, cellular, genetic and <molecular_char>epigenetic characterization</molecular_char> of an orthotopic xenograft derived from a high-risk stage 4 neuroblastoma patient.
(5) Here we present the detailed molecular, cellular, genetic and epigenetic characterization of an <model_type>orthotopic xenograft</model_type> derived from a high-risk stage 4 neuroblastoma patient.
(6) Here we present the detailed molecular, cellular, genetic and epigenetic characterization of an orthotopic xenograft derived from a high-risk <cancer_stage>stage 4</cancer_stage> neuroblastoma patient.
(7) Here we present the detailed molecular, cellular, genetic and epigenetic characterization of an orthotopic xenograft derived from a high-risk stage 4 <diagnosis>neuroblastoma</diagnosis> patient.


Input: 
Embryonal rhabdomyosarcoma is a pediatric cancer of the developing sympathoadrenal lineage.
Output:
The entities in this sentence are:
{"diagnosis": [Embryonal rhabdomyosarcoma], "age_category": [pediatric]}
There are 2 entities in total. Now I will print out the sentence for 2 times, each time with only one entity marked, the rest of the sentence will be exactly the same as the original sentence.
(1) <diagnosis>Embryonal rhabdomyosarcoma</diagnosis> is a pediatric cancer of the developing sympathoadrenal lineage.
(2) Embryonal rhabdomyosarcoma is a <age_category>pediatric</age_category> cancer of the developing sympathoadrenal lineage.


Input: 
With these NOD-SCID PDXs, we performed in vivo compound screens using a 1 × 1 × 1 experimental design (PDX clinical trial or PCT) to assess the population responses to 62 treatments across six indications.
Output:
The entities in this sentence are:
{"model_type": [PDXs], "clinical_trial": [PDX clinical trial, PCT], "host_strain": [NOD-SCID]}
There are 4 entities in total. Now I will print out the sentence for 4 times, each time with only one entity marked, the rest of the sentence will be exactly the same as the original sentence.
(1) With these NOD-SCID <model_type>PDXs<model_type>, we performed in vivo compound screens using a 1 × 1 × 1 experimental design (PDX clinical trial or PCT) to assess the population responses to 62 treatments across six indications.
(2) With these NOD-SCID PDXs, we performed in vivo compound screens using a 1 × 1 × 1 experimental design (<clinical_trial>PDX clinical trial</clinical_trial> or PCT) to assess the population responses to 62 treatments across six indications.
(3) With these NOD-SCID PDXs, we performed in vivo compound screens using a 1 × 1 × 1 experimental design (PDX clinical trial or <clinical_trial>PCT<clinical_trial>) to assess the population responses to 62 treatments across six indications.
(4) With these <host_strain>NOD-SCID</host_strain> PDXs, we performed in vivo compound screens using a 1 × 1 × 1 experimental design (PDX clinical trial or PCT) to assess the population responses to 62 treatments across six indications.



Input:
Here we evaluate the capacity of patient-derived organoids (PDOs) to predict clinical drug response and functional consequences of tumor heterogeneity.
Output:
The entities in this sentence are:
{"model_type": [patient-derived organoids, PDOs]}
There are 2 entities in total. Now I will print out the sentence for 2 times, each time with only one entity marked, the rest of the sentence will be exactly the same as the original sentence.
(1) Here we evaluate the capacity of <model_type>patient-derived organoids</model_type> (PDOs) to predict clinical drug response and functional consequences of tumor heterogeneity.
(2) Here we evaluate the capacity of patient-derived organoids (<model_type>PDOs</model_type>) to predict clinical drug response and functional consequences of tumor heterogeneity.



Input: 
As autopsy specimens had an ALK R1181C mutation, PHLC402 cell line tumor were treated with the pan-kinase inhibitor lestaurtinib but demonstrated no decrease in tumor growth.
Output:
The entities in this sentence are:
{"sample_type": [autopsy], "biomarker": [ALK], "model_type": [cell line], "treatment": [pan-kinase inhibitor, lestaurtinib], "response_to_treatment": [decrease in tumor growth], "model_id": [PHLC402]}
There are 7 entities in total. Now I will print out the sentence for 7 times, each time with only one entity marked, the rest of the sentence will be exactly the same as the original sentence.
(1) As <sample_type>autopsy</sample_type> specimens had an ALK R1181C mutation, PHLC402 cell line tumor were treated with the pan-kinase inhibitor lestaurtinib but demonstrated no decrease in tumor growth.
(2) As autopsy specimens had an <biomarker>ALK<biomarker> R1181C mutation, PHLC402 cell line tumor were treated with the pan-kinase inhibitor lestaurtinib but demonstrated no decrease in tumor growth.
(3) As autopsy specimens had an ALK R1181C mutation, PHLC402 <model_type>cell line</model_type> tumor were treated with the pan-kinase inhibitor lestaurtinib but demonstrated no decrease in tumor growth.
(4) As autopsy specimens had an ALK R1181C mutation, PHLC402 cell line tumor were treated with the <treatment>pan-kinase inhibitor</treatment> lestaurtinib but demonstrated no decrease in tumor growth.
(5) As autopsy specimens had an ALK R1181C mutation, PHLC402 cell line tumor were treated with the pan-kinase inhibitor <treatment>lestaurtinib</treatment> but demonstrated no decrease in tumor growth.
(6) As autopsy specimens had an ALK R1181C mutation, PHLC402 cell line tumor were treated with the pan-kinase inhibitor lestaurtinib but demonstrated no <response_to_treatment>decrease in tumor growth</response_to_treatment>.
(7) As autopsy specimens had an ALK R1181C mutation, <model_id>PHLC402</model_id> cell line tumor were treated with the pan-kinase inhibitor lestaurtinib but demonstrated no decrease in tumor growth.
